Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis

Abstract

Pancreatic cancer is a common malignancy with a high mortality. Most patients present clinically with advanced pancreatic cancer. Moreover, the effect of radiotherapy or chemotherapy is limited. Complementary and alternative medicines represent exciting adjunctive therapies. In this study, we ascertained the beneficial and adverse effects of Chinese herbal medicine (CHM) in combination with conventional therapy for inoperable pancreatic cancer by using meta-analysis methods for controlled clinical trials. We extracted data for studies searched from six electronic databases that were searched and also assessed the methodological quality of the included studies. We evaluated the following outcome measures: 6-month and 1-year survival rate, objective response rate, disease control rate, quality of life, and adverse effects. The final analysis showed CHM is a promising strategy as an adjunctive therapy to treat advanced or inoperable pancreatic cancer and that CHM in combination with conventional therapy is a promising strategy for resistant disease. However, convincing evidence must be obtained and confirmed by high-quality trials in future studies.

Autophagy Protects from Raddeanin A‐Induced Apoptosis in SGC‐7901 Human Gastric Cancer Cells

“…Traditional Chinese medicine (TCM) could be an important supplement. However, convincing evidence must be obtained and confirmed by high-quality trials in future studies [2]. …”

Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements

“…Indeed, more than 60% of the current anticancer chemotherapeutic drugs used in clinic were initially developed from natural products/herbal medicines [ 11 ]. Natural products/herbal medicines, combined with conventional chemotherapy and radiotherapy, may enhance anticancer therapeutic efficacy and reduce the side effects [ 12 ]. In this context, the use of natural products/herbal medicines, as a supplementary approach, to treat pancreatic cancer holds a great promise.…”

Yangzheng Sanjie decoction regulates proliferation and apoptosis of gastric cancer cells by enhancing let-7a expression

“…As an important source of novel agents with pharmaceutical potential, Chinese herbal medicines have become increasingly popular in cancer treatment as alternative and complementary therapy modalities[ 2 - 6 ]. One Chinese medicine formula, Yangzheng Sanjie decoction (YZSJD), which contains the ingredients Astragali Radix, Scutellariae Barbatae Herba, Arisaematis Rhizoma Preparatum, Citri Sarcodactylis Fructus, Cremastrae Pseudobulbus and Curcumae Longae Rhizoma , has shown good clinical effects in the treatment of chronic atrophic gastritis with precancerous lesions[ 7 ].…”